enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Pembrolizumab - Wikipedia

   en.wikipedia.org/wiki/Pembrolizumab

   Pembrolizumab, sold under the brand name Keytruda, is a humanized antibody, more specifically a PD-1 Inhibitor, used in cancer immunotherapy that treats melanoma, lung cancer, head and neck cancer, Hodgkin lymphoma, stomach cancer, cervical cancer, and certain types of breast cancer.

3. ‘Pioneering’ drug for rare eye cancer to be rolled out on NHS ...

   www.aol.com/pioneering-drug-rare-eye-cancer...

   According to NHS England, trials have shown the chance of surviving three years after starting tebentafusp is 27 per cent compared with 18 per cent on the current standard treatment, which is ...

4. Personalized mRNA cancer vaccine therapy - Wikipedia

   en.wikipedia.org/wiki/Personalized_mRNA_cancer...

   Personalized mRNA cancer vaccine therapy is a therapy that uses a personalized cancer vaccine based on mRNA vaccine technology to target existing tumors in patients. As of 2024, number of mRNA cancer vaccines are in clinical trials, of which many are personalized therapies based on engineering mRNA-mediated immune response that targets the patient's particular strain of cancer cells.

5. Photoimmunotherapy - Wikipedia

   en.wikipedia.org/wiki/Photoimmunotherapy

   Photoimmunotherapy (PIT) is an oncological treatment that combines photodynamic therapy of tumor with immunotherapy treatment. Combining photodynamic therapy with immunotherapy enhances the immunostimulating response and has synergistic effects for metastatic cancer treatment. [1] [2] [3]

6. Women with advanced breast cancer get new immunotherapy on ...

   www.aol.com/women-advanced-breast-cancer...

   For premium support please call: 800-290-4726 more ways to reach us

7. Cancer immunotherapy - Wikipedia

   en.wikipedia.org/wiki/Cancer_immunotherapy

   Examples include therapeutic cancer vaccines (also known as treatment vaccines, [13] which are designed to boost the body's immune system to fight cancer), CAR-T cells, and targeted antibody therapies. In contrast, passive immunotherapy does not directly target tumor cells, but enhances the ability of the immune system to attack cancer cells.